Ona Therapeutics was launched in 2019 and is specialised in the discovery and development of therapeutic biologics targeting tumour metastasis-initiating cells and lipid metabolism. This therapeutic approach has the potential to prevent the formation of metastases and eliminate existing ones in multiple types of cancer. In 2020, Ona Therapeutics closed a large series A 30M investment round with an international expert syndicate of VCs.
Image
